Skip to Main Content

Business

STAT ‘s award-winning team of reporters covers every major health care industry in the United States, including pharma, biotech, hospitals, insurance, health tech and medical devices.

Latest

Business Lizzy Lawrence

STAT Plus: 3 key issues to watch at the FDA as Trump takes office

Health tech Mario Aguilar

STAT Plus: Four digital health unicorns on what they expect in 2025

Insurance Bob Herman

STAT Plus: Aetna lawsuit alleges radiology group of fraudulent billing and abuse of federal arbitration

Exclusive Rachel Cohrs Zhang

STAT Plus: PhRMA dues fell almost $100 million as major drugmakers exited

Health Care Inc. Newsletter Bob Herman

STAT Plus: A tough year for health insurance stocks as patients get more care

The Readout Meghana Keshavan

STAT Plus: Vertex drug for cystic fibrosis wins approval

A STAT Investigation Casey Ross, Bob Herman, Tara Bannow, and Lizzy Lawrence

STAT Plus: Health Care’s Colossus: Lawmakers call for curbs on UnitedHealth’s growing empire

Health tech Lizzy Lawrence

STAT Plus: FDA designates Neuralink brain implant, infectious disease tests as ‘breakthroughs’

All Coverage

Politics John Wilkerson, Sarah Owermohle, and Rachel Cohrs Zhang

STAT Plus: Republicans dropped measures to help kids with cancer from the spending bill. Democrats pounced.

Exclusive Tara Bannow

STAT Plus: New York health insurer, executive agree to up to $100 million settlement over Medicare fraud tied to improper diagnoses

advertisement

The Readout Meghana Keshavan

STAT Plus: Is a contrarian leader good for the FDA?

Business Rachel Cohrs Zhang

STAT Plus: House Republicans abandon PBM reform in push to keep government open

Business Lizzy Lawrence and Elizabeth Cooney

STAT Plus: FDA updates rules for which foods are ‘healthy,’ adding salmon and nuts and cutting sugary cereals

D.C. Diagnosis John Wilkerson

STAT Plus: The health care deal is in jeopardy

The Readout Elaine Chen

STAT Plus: Biotech stocks hammered after Fed rate projections

Business Tara Bannow

STAT Plus: Copy-pasted notes and untrained providers: First federal audit of autism therapy finds problems in every record

The Readout Elaine Chen

STAT Plus: A key decision on compounding is expected this week

D.C. Diagnosis Sarah Owermohle

STAT Plus: PBMs face scrutiny from all sides, and analyzing Marty Makary’s road to the FDA

The Readout Elaine Chen

STAT Plus: Gameto says first baby born using new stem-cell tech

Politics Rachel Cohrs Zhang

STAT Plus: Congress strikes deal to rein in PBMs after years of debate

Health Care Inc. Newsletter Bob Herman

STAT Plus: The AI denial fighters and health care’s rising profitability

The Readout Meghana Keshavan

STAT Plus: Viridian confirms benefit of drug for thyroid eye disease

Politics John Wilkerson

STAT Plus: Three major health care policy issues to watch in 2025

Business Chris Serres, Liz Kowalczyk, Elizabeth Koh, and Brendan McCarthy — Boston Globe

STAT Plus: Broken promises, lax scrutiny: Inside Massachusetts’s failure to regulate Steward Health

Pharmalot Ed Silverman

STAT Plus: Novo Holdings is set to close its $16.5 billion acquisition of Catalent after FTC declines to challenge the deal

The Readout Meghana Keshavan

STAT Plus: GLP-1 drugs spark disagreements in Trump’s circle

Insurance Bob Herman

STAT Plus: Centene warns Republicans against cutting Medicaid or letting ACA subsidies expire

The Readout Elaine Chen

STAT Plus: The biotech news you need to read today

Health tech Casey Ross

STAT Plus: AI versus AI: The emerging arms race over health insurance denials